The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
基本信息
- 批准号:9976465
- 负责人:
- 金额:$ 76.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Automobile DrivingBiogenesisBody fatCarbohydratesCell HypoxiaCell RespirationCellsClear CellDefectEquilibriumExhibitsExposure toFamilyFastingFatty AcidsFatty LiverGenesGenetic TranscriptionGlutamineGlycogenGlycolysisGoalsGrantHistologicHomeostasisHypoxiaIntracellular Accumulation of LipidsKidneyLinkLipidsMalignant NeoplasmsMetabolicMetabolismMitochondriaModalityMolecularMusMutationNuclearOxygen ConsumptionPPAR gammaPhenotypePhysiologyProductionProximal Kidney TubulesReactive Oxygen SpeciesRegulationRenal Cell CarcinomaRepressionRoleSignal TransductionSolid NeoplasmSourceTherapeuticThermogenesisTissuesTranscriptional ActivationTumor ExpansionTumor Suppressor GenesWild Type Mousecancer therapygenomic locusglucose uptakelipid biosynthesislipid metabolismnovelnovel therapeuticsoxidationpublic health relevancerespiratoryresponsetherapeutic targettranscription factortumortumor growthtumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The frequently altered expression of metabolism genes in solid tumors such as clear cell renal cell cancer (ccRCC) has reinforced the importance of dysregulated metabolism in driving tumor expansion. Indeed, constitutive activation of the hypoxia inducible transcription factor (HIF) through mutations in the von Hippel Lindau (VHL) tumor suppressor gene or through exposure to hypoxia, results in enhanced glucose uptake, glycolytic flux, lactate secretion and suppression of mitochondrial activity. Conversely, reactive oxygen species produced by the mitochondria stimulate HIF-dependent transcription, creating an intricate signaling loop that balances mitochondrial oxygen consumption with the cellular response to hypoxia. In addition to stimulating glycolysis while suppressing OXPHOS, hypoxia has also been demonstrated to stimulate de novo lipogenesis through reductive glutamine metabolism, although it has not yet known how this reductive glutamine metabolism contributes to lipid accumulation in solid tumors and the clear cell phenotype in ccRCC. Importantly, HIF-dependent metabolic changes have been exploited therapeutically, indicating that a more comprehensive understanding of HIF regulated metabolism may yield novel anti-cancer therapies. Oxidative metabolism, which broadly encompasses carbohydrate oxidation, glutamine oxidation, and fatty acid ß-oxidation, is controlled by a number of nuclear and mitochondrial transcription factors that together promote the biogenesis and enzymatic function of mitochondria and is often found repressed in many tumors including ccRCC. First identified for their role in promoting adaptive thermogenesis, the peroxisome proliferator activated receptor gamma coactivators PGC-1 and PGC-1ß promote mitochondrial biogenesis and OXPHOS activity in a wide range of tissues by stimulating the transcriptional activation potential of a number of nuclear transcription factors. PGC-1 and PGC-1ß are encoded by discrete genetic loci and exhibit both distinct and redundant transcriptional targets. Indeed, PGC-1 -/- mice exhibit multi-tissue defects in oxidative metabolism, indicating unique functions for PGC-1 that cannot be compensated for by PGC-1ß. Furthermore, PGC-1 deficient mice accumulate significantly more body fat than wild type mice, and develop fasting induced hepatic steatosis, suggesting an important role for PGC-1 in the regulation of lipid metabolism. While the functions of the PGC family have been extensively studied in normal physiology, their function in the context of malignancy has not been rigorously investigated. Our recent studies indicate that PGC-1 is suppressed in ccRCC through a HIF-/Dec1 transcriptional axis. The suppression of PGC-1 in VHL-wild type renal proximal tubule cells is associated with reduced mitochondrial activity and acquisition of the clear cell (lipid and glycogen accumulation) phenotype, a histological hallmark of ccRCC. These findings provide the first evidence linking the clear cell phenotype to multiple aspects of renal tumorigenesis and raise the potential for PGC-1 stimulation as a novel therapeutic modality in the treatment of renal cell carcinoma, and potentially other solid tumors. The goals of this grant are to explore the molecular mechanisms governing lipid homeostasis in cancer, characterize their contribution to tumorigenesis and identify ways that they can be therapeutically targeted in solid tumors and determine how to best exploit them therapeutically.
描述(申请人提供):代谢基因在实体肿瘤,如透明细胞肾细胞癌(CcRCC)中的表达频繁变化,加强了代谢失调在推动肿瘤扩张中的重要性。事实上,通过von Hippel Lindau(VHL)肿瘤抑制基因突变或暴露在低氧环境中,低氧诱导转录因子(HIF)的结构性激活,导致葡萄糖摄取、糖酵解通量、乳酸分泌增加和线粒体活性抑制。相反,线粒体产生的活性氧物种刺激依赖于HIF的转录,创建一个复杂的信号循环,平衡线粒体的氧气消耗和细胞对低氧的反应。除了在抑制OXPHOS的同时刺激糖酵解,低氧也被证明通过还原型谷氨酰胺代谢刺激新生脂肪生成,尽管目前还不知道这种还原型谷氨酰胺代谢如何促进实体瘤中的脂肪积累和ccRCC中的透明细胞表型。重要的是,HIF依赖的代谢变化已经被用于治疗,这表明更全面地了解HIF调节的代谢可能会产生新的抗癌疗法。氧化代谢包括碳水化合物氧化、谷氨酰胺氧化和脂肪酸氧化,受多种核和线粒体转录因子的控制,这些转录因子共同促进线粒体的生物发生和酶功能,在许多肿瘤中经常被发现抑制,包括肾细胞癌。过氧化体增殖物激活受体共激活剂pgc-1和pgc-1?通过刺激许多核转录因子的转录激活潜能,在广泛的组织中促进线粒体的生物发生和氧合酶的活性,首次被确定为促进适应性产热的作用。PGC-1和pGC-1?由离散的遗传位点编码,既有不同的转录靶点,也有多余的转录靶点。事实上,pGC-1-/-小鼠在氧化代谢方面表现出多个组织缺陷,表明pGC-1的独特功能不能被pgc-1?弥补。此外,pGC-1缺陷小鼠比野生型小鼠积累更多的体脂,并出现空腹引起的肝脏脂肪变性,提示pGC-1在脂代谢调节中起重要作用。虽然PGC家族在正常生理学中的功能已经被广泛研究,但它们在恶性肿瘤背景下的功能还没有得到严格的研究。我们最近的研究表明,PGC-1在肾细胞癌中是通过HIF-/DEC1转录轴被抑制的。野生型肾小管上皮细胞PGC-1的抑制与线粒体活性降低和获得透明细胞(脂质和糖原积聚)表型有关,而透明细胞是肾细胞癌的组织学标志。这些发现提供了第一个证据,将透明细胞表型与肾脏肿瘤发生的多个方面联系起来,并提高了pGC-1刺激作为治疗肾癌以及潜在的其他实体肿瘤的一种新的治疗方式的潜力。这笔赠款的目标是探索控制癌症中脂质动态平衡的分子机制,确定它们在肿瘤发生中的作用,确定它们可以作为实体肿瘤的治疗靶点的方法,并确定如何最好地利用它们进行治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amato J. Giaccia其他文献
Benzamides substitués et leurs utilisations
苯甲酰胺替代品和用途
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
M. Bonnet;Denise A. Chan;Amato J. Giaccia;Michael Patrick Hay;Edwin W. Lai;Olga V. Razorenova;Connie Sun;Ray Tabibiazar;Po - 通讯作者:
Po
88: Lysyl Oxidase Is Essential for Hypoxia-Induced Metastasis
- DOI:
10.1016/j.ijrobp.2006.07.118 - 发表时间:
2006-11-01 - 期刊:
- 影响因子:
- 作者:
Janine Erler;Quynh Le;Amato J. Giaccia - 通讯作者:
Amato J. Giaccia
Lysyl oxidase is essential for hypoxia-induced metastasis
赖氨酰氧化酶对于缺氧诱导的转移是必不可少的
- DOI:
10.1038/nature04695 - 发表时间:
2006-04-27 - 期刊:
- 影响因子:48.500
- 作者:
Janine T. Erler;Kevin L. Bennewith;Monica Nicolau;Nadja Dornhöfer;Christina Kong;Quynh-Thu Le;Jen-Tsan Ashley Chi;Stefanie S. Jeffrey;Amato J. Giaccia - 通讯作者:
Amato J. Giaccia
Hypoxic gene expression and metastasis
- DOI:
10.1023/b:canc.0000031768.89246.d7 - 发表时间:
2004-08-01 - 期刊:
- 影响因子:8.700
- 作者:
Quynh-Thu Le;Nicholas C. Denko;Amato J. Giaccia - 通讯作者:
Amato J. Giaccia
Therapeutic targeting of the functionally elusive TAM receptor family
对功能上难以捉摸的 TAM 受体家族的治疗靶向
- DOI:
10.1038/s41573-023-00846-8 - 发表时间:
2023-12-13 - 期刊:
- 影响因子:101.800
- 作者:
Yu Rebecca Miao;Erinn B. Rankin;Amato J. Giaccia - 通讯作者:
Amato J. Giaccia
Amato J. Giaccia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amato J. Giaccia', 18)}}的其他基金
Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
- 批准号:
10707880 - 财政年份:2022
- 资助金额:
$ 76.29万 - 项目类别:
Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
- 批准号:
10334199 - 财政年份:2022
- 资助金额:
$ 76.29万 - 项目类别:
Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer
针对晚期肾癌 AXL 的新疗法的临床前测试
- 批准号:
8949353 - 财政年份:2016
- 资助金额:
$ 76.29万 - 项目类别:
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
- 批准号:
10212325 - 财政年份:2015
- 资助金额:
$ 76.29万 - 项目类别:
HIF-1alpha, a Survival and Differentiation Factor for Cartilage
HIF-1alpha,软骨的存活和分化因子
- 批准号:
8609400 - 财政年份:2013
- 资助金额:
$ 76.29万 - 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
- 批准号:
8492949 - 财政年份:2011
- 资助金额:
$ 76.29万 - 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
- 批准号:
8208641 - 财政年份:2011
- 资助金额:
$ 76.29万 - 项目类别:
相似国自然基金
UMSC-Exo通过调控Ribosome biogenesis诱导心肌再生的策略及机制研究
- 批准号:82370264
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
活体动物线粒体biogenesis、fission及fusion对肝脏再生中能量供应影响机制的研究
- 批准号:81470878
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
相似海外基金
Biogenesis of the mitochondrial beta-barrel membrane protein at the intermembrane space.
膜间空间线粒体β-桶膜蛋白的生物发生。
- 批准号:
24K18071 - 财政年份:2024
- 资助金额:
$ 76.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
白血病幹細胞におけるRibosomal biogenesisの解明と治療戦略の構築
白血病干细胞核糖体生物发生的阐明和治疗策略的开发
- 批准号:
24H00639 - 财政年份:2024
- 资助金额:
$ 76.29万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
New mechanisms regulating the biogenesis of extracellular vesicles
调节细胞外囊泡生物发生的新机制
- 批准号:
DP240101427 - 财政年份:2024
- 资助金额:
$ 76.29万 - 项目类别:
Discovery Projects
DEL-1 Promotes Biogenesis of Mineralizing Extracellular Vesicles by Mediating Intracellular Calcium Signaling
DEL-1 通过介导细胞内钙信号传导促进矿化细胞外囊泡的生物合成
- 批准号:
24K19876 - 财政年份:2024
- 资助金额:
$ 76.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
MFB: Characterization of the Biogenesis, Uptake, and Cellular Response to the Ribonucleoprotein Cargoes of Extracellular Vesicles using EV-CLASP
MFB:使用 EV-CLASP 表征细胞外囊泡核糖核蛋白货物的生物合成、摄取和细胞反应
- 批准号:
2330665 - 财政年份:2024
- 资助金额:
$ 76.29万 - 项目类别:
Standard Grant
Mechanisms of PIKII-dependent transport during secretory granule biogenesis
分泌颗粒生物发生过程中 PIKII 依赖性运输的机制
- 批准号:
490594 - 财政年份:2023
- 资助金额:
$ 76.29万 - 项目类别:
Operating Grants
Changes in structure and biogenesis of Gram-negative envelope following a polymyxin challenge
多粘菌素攻击后革兰氏阴性包膜的结构和生物发生的变化
- 批准号:
BB/X000370/1 - 财政年份:2023
- 资助金额:
$ 76.29万 - 项目类别:
Research Grant
MITOCHONDRIA REDOX BIOGENESIS AND METABOLIC RAMAN IMAGING IN INSULIN SIGNALLING
胰岛素信号传导中的线粒体氧化还原生物发生和代谢拉曼成像
- 批准号:
2883511 - 财政年份:2023
- 资助金额:
$ 76.29万 - 项目类别:
Studentship
Molecular Mechanisms of Mitochondrial Biogenesis
线粒体生物发生的分子机制
- 批准号:
10735778 - 财政年份:2023
- 资助金额:
$ 76.29万 - 项目类别: